High-flow nasal cannula therapy for hypoxemic respiratory failure in patients with COVID-19

High-flow nasal cannula therapy for hypoxemic respiratory failure in patients with COVID-19

Introduction: High-flow nasal cannula (HFNC) therapy in patients with hypoxemic respiratory failure due to COVID-19 is poorly understood and remains controversial. Methods: We evaluated a large cohort of patients with COVID-19-related hypoxemic respiratory failure at the temporary COVID-19 hospital...

Full description

Bibliographic Details
Main Authors: Adrian Palacios Chavarria, Erika Salinas Lezama, Mauricio Gonzalez Navarro, Rafael Ricardo Valdez Vazquez, Héctor Herrera Bello, Julieta Lomelín Gascon, Linda Morales Juárez, Mónica Arboleya Avendaño, Luis Esteban Ramirez Gonzalez, Rodrigo Ville Benavides, Renate Victoria Álvarez Wyssmann, Brenda Sandoval Ortiz, Mariana Lizbeth Rodríguez de la Cerda, Lidia Moreno Castañeda, Luis Alberto Martinez-Juarez, Héctor Gallardo-Rincón, Roberto Tapia-Conyer
Format: Article
Language:English
Published: SAGE Publishing 2021-09-01
Series:Therapeutic Advances in Infectious Disease
Online Access:https://doi.org/10.1177/20499361211042959

Internet

https://doi.org/10.1177/20499361211042959

Similar Items